Synthekine Stock
Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders.
Sign up for SecondMarket™ to view the market and buy or sell Synthekine Stock
Buy + SellSee Synthekine Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Synthekine Stock Valuation + Share Prices
View real-time Tape D™ data on Synthekine stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedSynthekine Management Team
Director
Mardi Dier
Chief Medical Officer
Naiyer Rizvi
Director
Pablo J. Cagnoni
Director
Srinivas Akkaraju
Director
Larry Lasky
CEO
Debanjan Ray
Director
Julie Grant
Chief Development Officer
Martin Oft
Founder
Christopher Garcia
Director
Nils Lonberg
Synthekine Major Investors
Deerfield Management Company
Lilly Asia Ventures
Omega Funds
Samsara BioCapital
TCG X
Rock Springs Capital
Emerson Collective LLC
Canaan Partners
RA Capital Management LLC
Column Group
Learn More About Synthekine Stock
Buy Synthekine Stock
01Synthekine stock does not trade on public stock exchanges. Synthekine stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Synthekine stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Synthekine Stock
02Synthekine Stock does not trade on public stock exchanges. In order to sell Synthekine shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Synthekine Stock Price
03Synthekine does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Synthekine share price and other valuable private market data.
Read more about secondary market private company stock prices:
Synthekine Stock Ticker Symbol
04There is no ticker symbol for Synthekine stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Synthekine Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Synthekine stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Synthekine Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Synthekine stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Synthekine Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Synthekine IPO
08Synthekine is a private company and has not had an IPO. There is currently no Synthekine IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Synthekine IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Synthekine Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.